GS
NVAX icon

GTS Securities’s Novavax NVAX Stock Holding History

GTS Securities’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-266,400
Closed -$3.36M – 3147
2024
Q3 		$3.36M Sell
266,400
-240,400
-47% -$3.1M 0.01% 1188
2024
Q2 		$6.42M Buy
506,800
+294,800
+139% +$2.97M 0.01% 719
2024
Q1 		$1.01M Buy
212,000
+33,100
+19% +$154K ﹤0.01% 1964
2023
Q4 		$859K Sell
178,900
-152,800
-46% -$935K ﹤0.01% 2301
2023
Q3 		$2.4M Buy
+331,700
New +$2.65M ﹤0.01% 1398

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

GTS Securities's NVAX Position: Q4 2024 in Review

GTS Securities sold out of Novavax (NVAX) in Q4 2024, closing a stake of 46,501 shares — an estimated $587K sold.

GTS Securities first reported a position in NVAX in Q3 2023 and held it in 2 quarters. The position peaked at $587K in Q3 2024. 234 funds tracked by Wall St. Rank hold NVAX as of Q4 2024.

  • GTS Securities reported no remaining Novavax position as of Q4 2024 after selling out during the quarter.
  • GTS Securities sold 46,501 Novavax shares in Q4 2024, an estimated $587K.
  • GTS Securities first reported a position in Novavax in Q3 2023 and held it in 2 quarters.
  • GTS Securities's Novavax position peaked at $587K in Q3 2024.
  • 234 funds tracked by Wall St. Rank held Novavax as of Q4 2024.

Based on GTS Securities's 13F filing for Q4 2024, filed 18 Feb 2025.